Celiac disease is entering a new era of therapeutic innovation

Celiac disease is entering a new era of therapeutic innovation is a pharma and life sciences industry update from BioPharma Dive. The story may affect commercial strategy, market access planning, stakeholder engagement, competitive positioning, and near-term monitoring for pharmaceutical and biotech teams.

Paul Lizzul, M.D., Ph.D. · 2026-06-15

For the ~1 in 100 people living with celiac, the burden of disease extends far beyond their plate.

Source: BioPharma Dive